Position in OCGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$155,873
+$105,849 QoQ
Shares Held
86,118
+132.4% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,076,998,138 across 270 Biotechnology names. OCGN ranks #224 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,112 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,155 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,087 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,716 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,411 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,558 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,214 |
All Filings in OCGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $155,873 | 86,118 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $50,024 | 37,055 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $60,399 | 37,055 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $24,172 | 24,920 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $414,765 | 587,487 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $438,885 | 545,201 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $540,992 | 545,357 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,165,318 | 751,819 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $43,103 | 26,283 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $50,457 | 87,752 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $35,100 | 87,752 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $73,527 | 135,410 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $841,537 | 986,562 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,258,086 | 967,759 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,708,715 | 959,953 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,035,867 | 896,858 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,490,027 | 754,554 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $3,571,075 | 784,852 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,482,654 | 763,601 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $5,584,230 | 695,421 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $598,973 | 88,214 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||